SARS-CoV-2 and other respiratory pathogens are detected in continuous air samples from congregate settings

Author:

Ramuta Mitchell D.ORCID,Newman Christina M.,Brakefield Savannah F.,Stauss Miranda R.,Wiseman Roger W.,Kita-Yarbro Amanda,O’Connor Eli J.,Dahal Neeti,Lim Ailam,Poulsen Keith P.,Safdar Nasia,Marx John A.,Accola Molly A.,Rehrauer William M.,Zimmer Julia A.ORCID,Khubbar Manjeet,Beversdorf Lucas J.,Boehm Emma C.,Castañeda David,Rushford Clayton,Gregory Devon A.,Yao Joseph D.ORCID,Bhattacharyya Sanjib,Johnson Marc C.,Aliota Matthew T.ORCID,Friedrich Thomas C.ORCID,O’Connor David H.ORCID,O’Connor Shelby L.ORCID

Abstract

AbstractTwo years after the emergence of SARS-CoV-2, there is still a need for better ways to assess the risk of transmission in congregate spaces. We deployed active air samplers to monitor the presence of SARS-CoV-2 in real-world settings across communities in the Upper Midwestern states of Wisconsin and Minnesota. Over 29 weeks, we collected 527 air samples from 15 congregate settings. We detected 106 samples that were positive for SARS-CoV-2 viral RNA, demonstrating that SARS-CoV-2 can be detected in continuous air samples collected from a variety of real-world settings. We expanded the utility of air surveillance to test for 40 other respiratory pathogens. Surveillance data revealed differences in timing and location of SARS-CoV-2 and influenza A virus detection. In addition, we obtained SARS-CoV-2 genome sequences from air samples to identify variant lineages. Collectively, this shows air sampling is a scalable, high throughput surveillance tool that could be used in conjunction with other methods for detecting respiratory pathogens in congregate settings.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Reference77 articles.

1. Lee, J. S. et al. Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. PLoS One 16, e0260487 (2021).

2. Wu, K. J. ‘It’s Like Groundhog Day’: Coronavirus Testing Labs Again Lack Key Supplies. The New York Times (2020).

3. Supply shortages impacting COVID-19 and non-COVID testing. https://asm.org/Articles/2020/September/Clinical-Microbiology-Supply-Shortage-Collecti-1 (2021).

4. Vogels, C. B. F. et al. SalivaDirect: a simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Medicines 2, 263–280.e6 (2021).

5. CDC. COVID data tracker. Centers for Disease Control and Prevention https://covid.cdc.gov/covid-data-tracker/?ACSTrackingID=FCP_1_USCDC_2145-DM75072&ACSTrackingLabel=%5BProof%201%5D%2002.04.2022%20-%20COVID-19%20Data%20Tracker%20Weekly%20Review&deliveryName=FCP_1_USCDC_2145-DM75072 (2020).

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3